This report explores how smart insulin pens can improve diabetes outcomes by enhancing adherence, dosing accuracy, and real-world data capture. It outlines the challenges of insulin misuse, including missed doses and incorrect administration, and demonstrates how connected devices help address these gaps. Smart pens provide dose tracking, reminders, and integration with digital health platforms, enabling better patient-provider communication. The report highlights clinical, economic, and system-level benefits, including reduced hypoglycemia risk and improved glycemic control. It concludes that broader adoption of smart pens, supported by reimbursement and education, could significantly improve diabetes care efficiency and outcomes.

Join for free to read